-24.21% to Target, Citigroup Reiterates “Sell” Rating for Bed Bath & Beyond (BBBY) Stock; Eagle Capital Management Decreased Thermo Fisher Scientific (TMO) Stake

Among 30 analysts covering Bed Bath & Beyond (NASDAQ:BBBY), 2 have Buy rating, 7 Sell and 21 Hold. Therefore 7% are positive. Bed Bath & Beyond has $85 highest and $17 lowest target. $42.92’s average target is 91.35% above currents $22.43 stock price. Bed Bath & Beyond had 67 analyst reports since September 21, 2015 according to SRatingsIntel. The stock of Bed Bath & Beyond Inc. (NASDAQ:BBBY) earned “Sell” rating by Bank of America on Friday, June 23. Credit Agricole maintained the shares of BBBY in report on Friday, September 25 with “Neutral” rating. The stock of Bed Bath & Beyond Inc. (NASDAQ:BBBY) has “Underweight” rating given on Wednesday, January 27 by KeyBanc Capital Markets. The stock has “Neutral” rating by Credit Suisse on Thursday, June 23. The stock of Bed Bath & Beyond Inc. (NASDAQ:BBBY) earned “Hold” rating by BTIG Research on Friday, June 23. Barclays Capital maintained Bed Bath & Beyond Inc. (NASDAQ:BBBY) on Wednesday, September 20 with “Equal-Weight” rating. SunTrust maintained the shares of BBBY in report on Monday, September 21 with “Buy” rating. The firm has “Hold” rating given on Thursday, October 8 by Jefferies. The company was maintained on Wednesday, December 23 by Telsey Advisory Group. As per Wednesday, September 20, the company rating was maintained by Bank of America.

Eagle Capital Management Llc decreased Thermo Fisher Scientific Inc (TMO) stake by 1.3% reported in 2017Q3 SEC filing. Eagle Capital Management Llc sold 47,734 shares as Thermo Fisher Scientific Inc (TMO)’s stock rose 8.13%. The Eagle Capital Management Llc holds 3.62 million shares with $684.55M value, down from 3.67 million last quarter. Thermo Fisher Scientific Inc now has $76.36B valuation. The stock decreased 0.37% or $0.71 during the last trading session, reaching $190.42. About 1.09 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 15.57% since December 24, 2016 and is uptrending. It has underperformed by 1.13% the S&P500.

The stock increased 4.30% or $0.93 during the last trading session, reaching $22.43. About 11.08M shares traded or 131.78% up from the average. Bed Bath & Beyond Inc. (NASDAQ:BBBY) has declined 16.34% since December 24, 2016 and is downtrending. It has underperformed by 33.04% the S&P500.

Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. The company has market cap of $3.21 billion. It sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and juvenile products. It has a 5.73 P/E ratio. It also provides various textile products, amenities, and other goods to institutional clients in the hospitality, cruise line, healthcare, and other industries.

Investors sentiment increased to 0.81 in 2017 Q3. Its up 0.06, from 0.75 in 2017Q2. It is positive, as 84 investors sold Bed Bath & Beyond Inc. shares while 103 reduced holdings. 39 funds opened positions while 113 raised stakes. 129.74 million shares or 2.88% less from 133.60 million shares in 2017Q2 were reported. Glenmede Tru Na owns 26,053 shares. Parallax Volatility Advisers Lp has 0% invested in Bed Bath & Beyond Inc. (NASDAQ:BBBY). Lafayette Invests Inc owns 0.76% invested in Bed Bath & Beyond Inc. (NASDAQ:BBBY) for 86,996 shares. Sei Invs, Pennsylvania-based fund reported 206,279 shares. Twin Mgmt owns 59,498 shares for 0.07% of their portfolio. Primecap Mgmt Company Ca reported 1.32M shares or 0.03% of all its holdings. D E Shaw invested 0.01% of its portfolio in Bed Bath & Beyond Inc. (NASDAQ:BBBY). Paloma Prtnrs stated it has 0.03% in Bed Bath & Beyond Inc. (NASDAQ:BBBY). 156,875 were reported by Wells Fargo And Mn. Laurion Capital Lp stated it has 364,500 shares or 0.04% of all its holdings. Ftb Advsrs has 630 shares for 0% of their portfolio. Numeric Investors Ltd Liability Co reported 53,300 shares. New York State Common Retirement Fund reported 0.01% of its portfolio in Bed Bath & Beyond Inc. (NASDAQ:BBBY). Dubuque Natl Bank & Co invested 0% in Bed Bath & Beyond Inc. (NASDAQ:BBBY). Amp Capital Invsts holds 0.03% in Bed Bath & Beyond Inc. (NASDAQ:BBBY) or 193,125 shares.

Since August 2, 2017, it had 0 insider purchases, and 7 insider sales for $18.71 million activity. Shares for $721,091 were sold by HORNSTRA PETER E on Tuesday, September 5. 11,318 Thermo Fisher Scientific Inc. (NYSE:TMO) shares with value of $1.96M were sold by MANZI JIM P. $9.59M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by CASPER MARC N. Herrema Gregory J. sold $5.28M worth of stock. HOOGASIAN SETH H sold $736,092 worth of Thermo Fisher Scientific Inc. (NYSE:TMO) on Monday, August 28. HARRIS C MARTIN sold $65,149 worth of stock or 360 shares. Shine Daniel P sold $366,645 worth of stock or 2,026 shares.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on January, 30. They expect $2.66 earnings per share, up 10.37% or $0.25 from last year’s $2.41 per share. TMO’s profit will be $1.07B for 17.90 P/E if the $2.66 EPS becomes a reality. After $2.31 actual earnings per share reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts 15.15% EPS growth.